Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
暂无分享,去创建一个
Chuang Liu | Jin Huang | Feixiong Cheng | Guixia Liu | Yun Tang | Weihua Li | Wei-Xing Zhou | Jing Jiang | Weiqiang Lu | F. Cheng | Weihua Li | Guixia Liu | Yun Tang | Wei‐Xing Zhou | Weiqiang Lu | Jin Huang | Chuang Liu | Jing Jiang
[1] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[2] John Riedl,et al. Item-based collaborative filtering recommendation algorithms , 2001, WWW '01.
[3] C. Ferland,et al. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism. , 2006, The Journal of allergy and clinical immunology.
[4] S. Brunak,et al. Generating Genome‐Scale Candidate Gene Lists for Pharmacogenomics , 2009, Clinical pharmacology and therapeutics.
[5] Cristian R. Munteanu,et al. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae. , 2011, Journal of proteome research.
[6] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[7] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[8] Lewis E Kazis,et al. Simvastatin is associated with a reduced incidence of dementia and Parkinson ' s disease , 2007 .
[9] D Wallwiener,et al. Inhibitory effect of statins on the proliferation of human breast cancer cells. , 2004, International journal of clinical pharmacology and therapeutics.
[10] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[11] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[12] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[13] R. D. Gietz,et al. Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. , 2002, Methods in enzymology.
[14] R. Solé,et al. Data completeness—the Achilles heel of drug-target networks , 2008, Nature Biotechnology.
[15] Michael Q. Zhang,et al. Network-based global inference of human disease genes , 2008, Molecular systems biology.
[16] G. Celesia,et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.
[17] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[18] A. Chiang,et al. Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses , 2009, Clinical pharmacology and therapeutics.
[19] Philip E. Bourne,et al. Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir , 2011, PLoS Comput. Biol..
[20] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[21] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[22] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[23] J. Lehmann,et al. Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.
[24] J A Stock,et al. Ketoconazole for prevention of postoperative penile erection. , 1995, Urology.
[25] Yi-Cheng Zhang,et al. Solving the apparent diversity-accuracy dilemma of recommender systems , 2008, Proceedings of the National Academy of Sciences.
[26] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[27] S. Tiwari-Woodruff,et al. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[28] W. Kuschner,et al. The Effect of an Inhaled Corticosteroid on Glucose Control in Type 2 Diabetes , 2009, Clinical Medicine & Research.
[29] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[30] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[31] Alexander A. Morgan,et al. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.
[32] K. Chou,et al. Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.
[33] Rhonda R. Voskuhl,et al. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)α and ERβ ligand treatment , 2007, Proceedings of the National Academy of Sciences.
[34] A. Peterson,et al. Use of oral ketoconazole to prevent postoperative erections following penile surgery , 2004, International Journal of Impotence Research.
[35] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[36] G. Veeneman,et al. Non-steroidal subtype selective estrogens. , 2005, Current medicinal chemistry.
[37] Alexander A. Morgan,et al. Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.
[38] M. Kanehisa,et al. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. , 2003, Journal of the American Chemical Society.
[39] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[40] Jonathan L. Herlocker,et al. Evaluating collaborative filtering recommender systems , 2004, TOIS.
[41] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[42] Weihua Li,et al. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening. , 2010, Journal of medicinal chemistry.
[43] Rhonda R. Voskuhl,et al. Treatment with an Estrogen Receptor α Ligand Is Neuroprotective in Experimental Autoimmune Encephalomyelitis , 2006, The Journal of Neuroscience.
[44] Jin Huang,et al. Butyl 4-(butyryloxy)benzoate functions as a new selective estrogen receptor β agonist and induces GLUT4 expression in CHO-K1 cells , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[45] Yoshihiro Yamanishi,et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..
[46] M. Boguski,et al. Repurposing with a Difference , 2009, Science.
[47] R. Evans,et al. Identification of a new class of steroid hormone receptors , 1988, Nature.
[48] Antje Chang,et al. New Developments , 2003 .
[49] B. Roth,et al. Molecular biology of serotonin receptors structure and function at the molecular level. , 2002, Current topics in medicinal chemistry.
[50] Rena Zhang,et al. Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection. , 2003, Journal of pharmaceutical and biomedical analysis.
[51] Bing-Hong Wang,et al. Accurate and diverse recommendations via eliminating redundant correlations , 2008, 0805.4127.
[52] Lin He,et al. Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome — Clozapine-Induced Agranulocytosis as a Case Study , 2011, PLoS Comput. Biol..
[53] Yu Cao,et al. NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling. , 2010, Cancer cell.
[54] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..
[55] J. Lehmann,et al. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. , 1997, The Journal of biological chemistry.